What Researchers Did
This pilot study evaluated the effectiveness of a vaginal natural oxygenation device (VNOD) delivering hyaluronic acid and topical hyperbaric oxygen therapy for vulvo-vaginal atrophy in 25 postmenopausal patients.
What They Found
Among 25 postmenopausal patients with severe vulvo-vaginal atrophy, significant improvements were observed in well-being (0.3 vs. 5.1, p < 0.001), vaginal burning (0.2 vs. 5.1, p < 0.001), and vaginal elasticity (1.1 vs. 3.8, p < 0.001) from baseline to the end of five biweekly treatments. All patients also reported a recovery of their sexuality after the treatment sessions.
What This Means for Canadian Patients
Canadian patients experiencing severe vulvo-vaginal atrophy might potentially benefit from this novel treatment approach, which combines hyaluronic acid and topical hyperbaric oxygen. This could offer a new non-hormonal option to alleviate symptoms like dryness, burning, and improve sexual well-being.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Italy.
Study Limitations
This was a pilot study with a small sample size of 25 patients, limiting the generalizability of its findings.